Therapy Areas: Infectious Diseases
9 November 2018 - - US-based clinical-stage company Vedanta Biosciences has released preclinical data for VE800, the company's orally-administered, live biotherapeutic product candidate in immuno...
8 November 2018 - - Austrian immunomodulation therapies developer Themis Bioscience has published the Phase 2 results of its lead vaccine candidate (MV-CHIK) in The Lancet, the company said....
5 November 2018 - Bavarian Nordic A/S (CPH:BAVA) (OTC: BVNRY), a fully integrated biotechnology company, announced on Friday the dosing of the first patient in a clinical study evaluating CV301, the c...
31 October 2018 - - US-based molecular diagnostics company Co-Diagnostics, Inc. (NASDAQ: CODX) and LGC, Biosearch Technologies, a specialist in the design, development, and manufacture of sophisticate...
30 October 2018 - It was reported yesterday that NanoViricides Inc (NYSE Amer: NNVC), a leader in developing novel nanomedicines to treat viral diseases, has named James Sapirstein as the Independent ...
29 October 2018 - - Anglo-Dutch medical journal The Lancet Infectious Diseases has published clinical results from the pivotal randomised controlled trial evaluating cefiderocol for the treatment of c...
Related Headlines